Monday, 24 November 2014

study Taranabant


Taranabant is a cannabinoid 1 receptor changed agonist that was in development for analysis of obesity. Because of axial afraid arrangement effects, the abstraction was performed to appraise the corruption abeyant and cerebral furnishings of taranabant in recreational polydrug users compared with phentermine, dronabinol, and placebo.
Stimulant- and cannabis-experienced polydrug users (N = 30) were randomized in a double-blind crossover abstraction to accept taranabant 2, 4, 10, and 20 mg; phentermine 45 and 90 mg; dronabinol 20 mg; and placebo. Abstract and neurocognitive measures were administered for 24 hours, and peak/peak change from baseline furnishings were analyzed application a beeline mixed-effects model.
Phentermine 45 and 90 mg showed abuse-related abstract furnishings against placebo, including biologic liking, all-embracing biologic liking, and added positive/stimulant effects, admitting dronabinol 20 mg showed abuse-related positive, cannabis-like, and allaying effects. Taranabant was not decidedly altered from placebo on a lot of of the abstract measures added than negative/dysphoric furnishings at the accomplished dose, and its furnishings were decidedly beneath arresting about to phentermine and dronabinol on a lot of measures. Phentermine bigger cognitive/motor achievement and dronabinol broken motor/cognitive achievement on some measures, admitting taranabant 4 and 20 mg had accessory crime furnishings on chiral tracking.
The phentermine and dronabinol after-effects authenticate the authority and acuteness of the study. Taranabant did not consistently appearance stimulant/cannabis-like furnishings or corruption abeyant in recreational polydrug users, advertence that cannabinoid 1 receptor changed agonists/antagonists are absurd to be recreationally abused.

Monday, 17 November 2014

Overview of D-Pyroglutamic Acid


CAS :4042-36-8
M.F. / M.W. :C5H7NO3=129.12
mp   155-162 °C
Solubility in Water:very faint turbidity
D-Pyroglutamic Acid Hazardous in case of skin contact irritant of eye contact irritant, corrosive of ingestion, of inhalation. Slightly hazardous in case of skin contact corrosive. Severe over-exposure can result in death.

Wednesday, 12 November 2014

About LEAD(II) ARSENATE


name: LEAD(II) ARSENATE
Synonymes: Soprabel; Talbot; ; triplumbous diarsorate
Formule moléculaire: H3AsO4Pb
Poids Moléculaire :349.143
InChI :InChI=1/AsH3O4.Pb.4H/c2-1(3,4)5;;;;;/h(H3,2,3,4,5);;;;;/q;+2;;;;/p-2/rAsH3O4.H4Pb/c2-1(3,4)5;/h(H3,2,3,4,5);1H4/q;+2/p-2
CAS: 3687-31-8
Point de fusion :382

Monday, 10 November 2014

Isopsoralen accord to anti-cancer effect


Psoralea corylifolia L. (Fabaceae) is a broadly acclimated medical bulb in China. This abstraction was advised to awning and analyze bioactive compounds with anticancer action from the seeds of Psoralea corylifolia L. One airy atom (fraction I) and three added fractions (fraction II, III, IV) from booze abstraction of P. corylifolia L. were obtained. Bioactivities of these fractions were evaluated by the cytotoxicity on KB, KBv200, K562, K562/ADM blight beef with MTT assay. Above apparatus in the alive atom were articular by HPLC/MSn. Atom IV decidedly inhibits the advance of blight beef in a dose-dependent manner. The IC50 ethics were 21.6, 24.4, 10.0 and 26.9, respectively. Psoralen and isopsoralen, abandoned from atom IV, were accountable to bioactive appraisal and presented a dose-dependent anticancer action in four blight corpuscle curve (KB, KBv200, K562 and K562/ADM). The IC50 ethics of psoralen were 88.1, 86.6, 24.4 and 62.6, which of isopsoralen were 61.9, 49.4, 49.6 and 72.0, respectively. Apoptosis of bump corpuscle decidedly added afterwards advised with psoralen and isopsoralen. Consecration of apoptotic action was accepted by breeze cytometry afterwards staining with Annexin V/PI. These after-effects appropriate psoralen and isopsoralen accord to anticancer aftereffect of P. corylifolia L.

Wednesday, 5 November 2014

Property of Gadolinium Sulfate


Name:Gadolinium Sulfate
CAS Number: 13450-87-8
Molecular Weight: 746.81
Molecular Formula: Gd2H16O20S3
MDL Number: MFCD00149734
Color and Form: white xtl.
Purity:99.99%

Monday, 3 November 2014

Teniposide reduce cancer cell growth


Teniposide (Vumon, VM-26) is a chemotherapeutic medication  mainly used in the treatment of childhood acute lymphocytic leukemia (ALL). It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.
Teniposide is used with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; a type of cancer of the white blood cells) in children that has not improved or that has worsened after treatment with other medications. Teniposide is in a class of medications known as podophyllotoxin derivatives. It works by slowing or stopping the growth of cancer cells in your body.